Time course proteomic profiling of human myocardial infarction plasma samples: An approach to new biomarker discovery

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1086-1093

  Silbiger, Vivian Nogueira ^a,c   Luchessi, André Ducati ^a   Hirata, Rosario Dominguez Crespo ^a   Neto, Lidio Gonçalves Lima ^a   Pastorelli, Carla Prisinzano ^a   Ueda, Eric K M ^a   Santos, Elizabete Silva dos ^b   Pereira, Marcos Paulo ^b   Ramos, Rui ^b   Sampaio, Marcelo Ferraz ^b   Armaganijan, Dikran ^b   Paik, Sun H ^d   Murata, Yoko ^d   Ooi, Guck T ^d   Ferguson, Earl W ^d   Hirata, Mario Hiroyuki ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d Sun BioMedical Technologies   (United States)

Author keywords

Acute myocardial infarction; Biomarker; Proteomics; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ERGOMETRY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TIME;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 79955034735     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.02.030     Document Type: Article

References (39)

1. Rajappa M., Sharma A. Biomarkers of cardiac injury: an update. Angiology 2005, 56:677-691.
2. Achar S.A., Kundu S., Norcross W.A. Diagnosis of acute coronary syndrome. Am Fam Physician 2005, 72:119-126.
3. Hong M., Zhang X., Hu Y., et al. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS. Thromb Res 2009, 123:556-564.
4. Macbeath G., Saghatelian A. The promise and challenge of '-omic' approaches. Curr Opin Chem Biol 2009, 13(5-6):501-502.
5. Huang Y.J., Xuan C., Zhang B.B., et al. SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res 2009, 28:85.
6. de Seny D., Fillet M., Meuwis M.A., et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 2005, 52:3801-3812.
7. Yip T.T., Lomas L. SELDI ProteinChip array in oncoproteomic research. Technol Cancer Res Treat 2002, 1:273-280.
8. Poon T.C., Yip T.T., Chan A.T., et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003, 49:752-760.
9. Gravett M.G., Novy M.J., Rosenfeld R.G., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004, 292:462-469.
10. Okrojek R., Grus F.H., Matheis N., Kahaly G.J. Proteomics in autoimmune thyroid eye disease. Horm Metab Res 2009, 41:465-470.
11. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 59:607-609.
12. Chalmers J., MacMahon S., Mancia G., et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999, 21:1009-1060.
13. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
14. III Guidelines on the treatment of myocardial acute infarction. Arq Bras Cardiol 2004, 83(Suppl 4):3-86.
15. Delon J., Desolneux A., Lisani J.L., Petro A.B. Color image segmentation using acceptable histogram segmentation. Pattern Recognition and Image Analysis, Pt 2, Proceedings 2005, 3523:239-246.
16. Desolneux A., Moisan L., Morel J.M. Meaningful alignments. Int J Comput Vision 2000, 40:7-23.
17. Desolneux A., Moisan L., Morel J.M. Edge detection by Helmholtz principle. J Math Imaging Vis 2001, 14:271-284.
18. Desolneux A., Moisan L., Morel J.M. A grouping principle and four applications. IEEE Trans Pattern Anal 2003, 25:508-513.
19. Fergurson E.W., Flenner A., Hewer G., Murata Y. Locating peaks in proteomic mass spectral data using the Morel-Helmholtz principle. 2006 IEEE International Symposium on Signal Processing and Information Technology 2006, vols. 1 and 2:217-221. 964.
20. Simon R., Lam A., Ngan M., Menenzes S., Zhoa Y. Analysis of gene expression data using BRB-Array tools. Cancer Inform 2007, 2:11-17.
21. Bourgon R., Gentleman R., Huber W. Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A 2010, 107:9546-9551.
22. Benjamini Y., Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc B Methodol 1995, 57:289-300.
23. Tang Y., Xu H., Du X., et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006, 26:1089-1102.
24. Mascarell-Creus A., Canizares J., Vilarrasa-Blasi J., et al. An oligo-based microarray offers novel transcriptomic approaches for the analysis of pathogen resistance and fruit quality traits in melon (Cucumis melo L.). BMC Genomics 2009, 10:467.
25. Puntmann V.O. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J 2009, 85:538-545.
26. Colburn W.A. Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development. J Clin Pharmacol 2000, 40:1419-1427.
27. Shiwa M., Nishimura Y., Wakatabe R., et al. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun 2003, 309:18-25.
28. Xu G., Xiang C.Q., Lu Y., et al. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett 2009, 282:205-213.
29. Delbosc S., Haloui M., Louedec L., et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med 2008, 14:383-394.
30. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-U672.
31. Zhang G., Zhou B., Zheng Y., et al. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis. Int J Cardiol 2009, 131:225-233.
32. Melle C., Camacho J.A., Surber R., Betge S., Von Eggeling F., Zimmer T. Region-specific alterations of global protein expression in the remodelled rat myocardium. Int J Mol Med 2006, 18:1207-1215.
33. Blanco-Colio L.M., Martin-Ventura J.L., Munoz-Garcia B., et al. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:916-922.
34. Florian-Kujawski M., Hussain W., Chyna B., et al. Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysis. Int Angiol 2004, 23:246-254.
35. Simpson R.J., Lim J.W.E., Moritz R.L., Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 2009, 6:267-283.
36. Daubert M.A., Jeremias A. The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag 2010, 6:691-699.
37. Hochholzer W., Morrow D.A., Giugliano R.P. Novel biomarkers in cardiovascular disease: update 2010. Am Heart J 2010, 160:583-594.
38. Chan D., Ng L.L. Biomarkers in acute myocardial infarction. BMC Med 2010, 8:34.
39. Coats A.J. Ethical authorship and publishing. Int J Cardiol 2009, 131:149-150.